3 ms·
There is another hypothesis that an immunocompromised patient who took some type of drug that induces DNA mutations in the coronavirus, similar to what Merck an
by mycall 5y ago
There is another hypothesis that an immunocompromised patient who took some type of drug that induces DNA mutations in the coronavirus, similar to what Merck and Ridgeback Biotherapeutics offers. If COVID-19 stayed in the patient's body for a long time, it would have time to cause many mutations before transmission.
- Scoundreller 5y agoThere’s no shortage of people regularly inhaling carcinogens either.
- throwawaysea 5y ago> If COVID-19 stayed in the patient's body for a long time Related article (https://arstechnica.com/science/2021/09/recent-ebola-outbreak-emerged-from-someone-infected-five-years-earlier/ https://arstechnica.com/science/2021/09/recent-ebola-outbrea...): “Recent Ebola outbreak emerged from someone infected 5 years earlier” In that case the lack of mutations is how they estimated the lengthy dormant period.